Bio-Gene Technology Ltd
BGT
Company Profile
Business description
Bio-Gene Technology Ltd is to pursue the development and commercialisation of naturally derived insecticide products. Its insecticide active ingredients are Flavocide, a synthetically produced nature-identical compound, and Qcide, a natural plant-derived oil with high levels of tasmanone. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.
Contact
400 Collins Street
Level 6
MelbourneVIC3000
AUST: +61 390681062
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
Employees
Stocks News & Analysis
stocks
CBA earnings: Business lending powers on, but costs and credit bear watching
Our view after the bank reports first quarter earnings.
stocks
Apple earnings review: Revenue beats estimates as memory crunch threatens margins
Apple shares are trading at record highs after posting solid results.
stocks
Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil
We’re reducing our long-term revenue estimates.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,208.60 | 65.60 | -0.71% |
| CAC 40 | 8,361.36 | 28.49 | 0.34% |
| DAX 40 | 26,771.88 | 109.11 | 0.41% |
| Dow JONES (US) | 52,297.09 | 189.40 | -0.36% |
| FTSE 100 | 10,863.09 | 27.62 | 0.25% |
| HKSE | 24,008.55 | 307.37 | -1.26% |
| NASDAQ | 25,366.09 | 100.10 | -0.39% |
| Nikkei 225 | 61,617.01 | 797.65 | 1.31% |
| NZX 50 Index | 14,160.89 | 98.34 | -0.69% |
| S&P 500 | 7,592.40 | 26.98 | -0.35% |
| S&P/ASX 200 | 9,084.90 | 61.90 | -0.68% |
| SSE Composite Index | 3,655.83 | 24.81 | -0.67% |